Partnership to execute next generation Covid-19 vaccines clinical trial
Drug Discovery World
SEPTEMBER 18, 2023
Against this backdrop, the Government & Public Health Solutions team at ICON will execute a Phase IIb clinical trial to assess the relative efficacy of a next generation Covid-19 vaccine compared to currently approved/authorised Covid-19 vaccines in the prevention of symptomatic, PCR confirmed SARS-CoV-2 infection.
Let's personalize your content